文献速递神经肿瘤

内镜经鼻垂体手术中预先向海绵窦注射止血剂塑形技术:技术说明

Pretreating cavernous sinus with hemostatic agent injection molding during endoscopic endonasal pituitary surgery: technical note.
PubMed 文献 · Acta Neurochir (Wien) · 2022-06-10

该技术说明纳入2017年11月至2021年6月内镜经鼻垂体腺瘤切除术中采用海绵窦止血剂注射塑形技术预处理止血的全部38例患者,在海绵窦内操作前于窦壁小切口并轻柔加压注射止血剂使其沿静脉通道分布形成部分塑形;结果显示该技术操作可行,可控制窦内出血,术后未观察到颞叶水肿、出血及眼球突出等并发症。

要点

  • 38例需行海绵窦内操作的垂体腺瘤患者采用海绵窦止血剂注射塑形技术预处理。
  • 将头端1 cm向上弯折45°的定制细钝金属管是实现注射的最佳器械。
  • 多点注射更有利于控制海绵窦不同分区,止血效果更好并有助于减少三叉神经心脏反射的影响。

核心结论

  • 内镜经鼻垂体手术中采用海绵窦止血剂注射塑形技术预处理海绵窦,是一种实用、有效且安全的窦内出血控制方法。

研究设计与样本

  • 技术说明,纳入2017年11月至2021年6月内镜经鼻垂体腺瘤切除术中采用海绵窦止血剂注射塑形技术预处理止血的全部38例患者。

主要发现

  • 38例需行海绵窦内操作的垂体腺瘤患者采用该技术预处理。
  • 头端1 cm向上弯折45°的定制细钝金属管是实现注射的最佳器械。
  • 多点注射更有利于控制海绵窦不同分区,止血效果更好并有助于减少三叉神经心脏反射的影响。
  • 术后未观察到颞叶水肿、出血及眼球突出等并发症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To clarify the technical pearls of cavernous sinus molding technique with hemostatic agent injection during endoscopic endonasal pituitary surgery. METHODS: All patients pretreated with cavernous sinus hemostatic agent injection molding technique for hemostasis in endoscopic endonasal surgery for pituitary adenoma resection between November 2017 and June 2021 were included. A small incision was made in the cavernous sinus wall before intracavernous manipulation. The hemostatic agent was injected with gentle pressure. It spread along the venous channels and established partial molding of the cavernous sinus. Intraoperative bleeding, surgical field score, and complications were evaluated. RESULTS: Thirty-eight patients with pituitary adenoma requiring cavernous sinus manipulation were pretreated with this technique. Technically, the tailored thin blunt metal tube with its 1 cm head end bended up 45° were the best instrument to accomplish injection. Multi-spot injections were preferred to control different compartments of the cavernous sinus, which both had a better effect in bleeding control and helped to reduce the influence of trigemino-cardiac reflex. Postoperative complications, including temporal lobe edema, hemorrhage, and exophthalmos were not observed. CONCLUSION: Pretreating cavernous sinus with hemostatic agent injection molding technique during endoscopic endonasal pituitary surgery is a practical, effective and safe method for intracavernous bleeding control.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Heng L, Wang H, Zhang S, et al. Pretreating cavernous sinus with hemostatic agent injection molding during endoscopic endonasal pituitary surgery: technical note. Acta Neurochir (Wien). 2022. PMID: 35687171. doi:10.1007/s00701-022-05267-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。